Global Hepatitis B Vaccine (Recombinant) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
LPI (LP Information)' newest research report, the “Hepatitis B Vaccine (Recombinant) Industry Forecast” looks at past sales and reviews total world Hepatitis B Vaccine (Recombinant) sales in 2022, providing a comprehensive analysis by region and market sector of projected Hepatitis B Vaccine (Recombinant) sales for 2023 through 2029. With Hepatitis B Vaccine (Recombinant) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis B Vaccine (Recombinant) industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis B Vaccine (Recombinant) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis B Vaccine (Recombinant) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hepatitis B Vaccine (Recombinant) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis B Vaccine (Recombinant) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis B Vaccine (Recombinant).
The global Hepatitis B Vaccine (Recombinant) market size is projected to grow from US$ 999.6 million in 2022 to US$ 1247.5 million in 2029; it is expected to grow at a CAGR of 1247.5 from 2023 to 2029.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 31%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Vaccine (Recombinant) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Hepatitis B Vaccine (Recombinant) market?
What factors are driving Hepatitis B Vaccine (Recombinant) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hepatitis B Vaccine (Recombinant) market opportunities vary by end market size?
How does Hepatitis B Vaccine (Recombinant) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
LPI (LP Information)' newest research report, the “Hepatitis B Vaccine (Recombinant) Industry Forecast” looks at past sales and reviews total world Hepatitis B Vaccine (Recombinant) sales in 2022, providing a comprehensive analysis by region and market sector of projected Hepatitis B Vaccine (Recombinant) sales for 2023 through 2029. With Hepatitis B Vaccine (Recombinant) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis B Vaccine (Recombinant) industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis B Vaccine (Recombinant) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis B Vaccine (Recombinant) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hepatitis B Vaccine (Recombinant) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis B Vaccine (Recombinant) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis B Vaccine (Recombinant).
The global Hepatitis B Vaccine (Recombinant) market size is projected to grow from US$ 999.6 million in 2022 to US$ 1247.5 million in 2029; it is expected to grow at a CAGR of 1247.5 from 2023 to 2029.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 31%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Vaccine (Recombinant) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 10mcg/0.5ml
- 10mcg/ml
- Newborn
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Merck
- Sanofi Pasteur
- Dynavax Technologies
- LG Life Sciences
- KM Biologics
- Shenzhen Kangtai Biological Products
- Serum Institute
What is the 10-year outlook for the global Hepatitis B Vaccine (Recombinant) market?
What factors are driving Hepatitis B Vaccine (Recombinant) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hepatitis B Vaccine (Recombinant) market opportunities vary by end market size?
How does Hepatitis B Vaccine (Recombinant) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hepatitis B Vaccine (Recombinant) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hepatitis B Vaccine (Recombinant) by Country/Region, 2018, 2022 & 2029
2.2 Hepatitis B Vaccine (Recombinant) Segment by Type
2.2.1 10mcg/0.5ml
2.2.2 10mcg/ml
2.3 Hepatitis B Vaccine (Recombinant) Sales by Type
2.3.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
2.3.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Type (2018-2023)
2.4 Hepatitis B Vaccine (Recombinant) Segment by Application
2.4.1 Newborn
2.4.2 Adult
2.5 Hepatitis B Vaccine (Recombinant) Sales by Application
2.5.1 Global Hepatitis B Vaccine (Recombinant) Sale Market Share by Application (2018-2023)
2.5.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Application (2018-2023)
3 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) BY COMPANY
3.1 Global Hepatitis B Vaccine (Recombinant) Breakdown Data by Company
3.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Company (2018-2023)
3.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Company (2018-2023)
3.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Company (2018-2023)
3.2.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Company (2018-2023)
3.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company (2018-2023)
3.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Company
3.4 Key Manufacturers Hepatitis B Vaccine (Recombinant) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis B Vaccine (Recombinant) Product Location Distribution
3.4.2 Players Hepatitis B Vaccine (Recombinant) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEPATITIS B VACCINE (RECOMBINANT) BY GEOGRAPHIC REGION
4.1 World Historic Hepatitis B Vaccine (Recombinant) Market Size by Geographic Region (2018-2023)
4.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hepatitis B Vaccine (Recombinant) Market Size by Country/Region (2018-2023)
4.2.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hepatitis B Vaccine (Recombinant) Sales Growth
4.4 APAC Hepatitis B Vaccine (Recombinant) Sales Growth
4.5 Europe Hepatitis B Vaccine (Recombinant) Sales Growth
4.6 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Growth
5 AMERICAS
5.1 Americas Hepatitis B Vaccine (Recombinant) Sales by Country
5.1.1 Americas Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023)
5.1.2 Americas Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023)
5.2 Americas Hepatitis B Vaccine (Recombinant) Sales by Type
5.3 Americas Hepatitis B Vaccine (Recombinant) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis B Vaccine (Recombinant) Sales by Region
6.1.1 APAC Hepatitis B Vaccine (Recombinant) Sales by Region (2018-2023)
6.1.2 APAC Hepatitis B Vaccine (Recombinant) Revenue by Region (2018-2023)
6.2 APAC Hepatitis B Vaccine (Recombinant) Sales by Type
6.3 APAC Hepatitis B Vaccine (Recombinant) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hepatitis B Vaccine (Recombinant) by Country
7.1.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023)
7.1.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023)
7.2 Europe Hepatitis B Vaccine (Recombinant) Sales by Type
7.3 Europe Hepatitis B Vaccine (Recombinant) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatitis B Vaccine (Recombinant) by Country
8.1.1 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023)
8.2 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Type
8.3 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis B Vaccine (Recombinant)
10.3 Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)
10.4 Industry Chain Structure of Hepatitis B Vaccine (Recombinant)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis B Vaccine (Recombinant) Distributors
11.3 Hepatitis B Vaccine (Recombinant) Customer
12 WORLD FORECAST REVIEW FOR HEPATITIS B VACCINE (RECOMBINANT) BY GEOGRAPHIC REGION
12.1 Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region
12.1.1 Global Hepatitis B Vaccine (Recombinant) Forecast by Region (2024-2029)
12.1.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis B Vaccine (Recombinant) Forecast by Type
12.7 Global Hepatitis B Vaccine (Recombinant) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Dynavax Technologies
13.4.1 Dynavax Technologies Company Information
13.4.2 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dynavax Technologies Main Business Overview
13.4.5 Dynavax Technologies Latest Developments
13.5 LG Life Sciences
13.5.1 LG Life Sciences Company Information
13.5.2 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 LG Life Sciences Main Business Overview
13.5.5 LG Life Sciences Latest Developments
13.6 KM Biologics
13.6.1 KM Biologics Company Information
13.6.2 KM Biologics Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 KM Biologics Main Business Overview
13.6.5 KM Biologics Latest Developments
13.7 Shenzhen Kangtai Biological Products
13.7.1 Shenzhen Kangtai Biological Products Company Information
13.7.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shenzhen Kangtai Biological Products Main Business Overview
13.7.5 Shenzhen Kangtai Biological Products Latest Developments
13.8 Serum Institute
13.8.1 Serum Institute Company Information
13.8.2 Serum Institute Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Serum Institute Main Business Overview
13.8.5 Serum Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hepatitis B Vaccine (Recombinant) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hepatitis B Vaccine (Recombinant) by Country/Region, 2018, 2022 & 2029
2.2 Hepatitis B Vaccine (Recombinant) Segment by Type
2.2.1 10mcg/0.5ml
2.2.2 10mcg/ml
2.3 Hepatitis B Vaccine (Recombinant) Sales by Type
2.3.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
2.3.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Type (2018-2023)
2.4 Hepatitis B Vaccine (Recombinant) Segment by Application
2.4.1 Newborn
2.4.2 Adult
2.5 Hepatitis B Vaccine (Recombinant) Sales by Application
2.5.1 Global Hepatitis B Vaccine (Recombinant) Sale Market Share by Application (2018-2023)
2.5.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Application (2018-2023)
3 GLOBAL HEPATITIS B VACCINE (RECOMBINANT) BY COMPANY
3.1 Global Hepatitis B Vaccine (Recombinant) Breakdown Data by Company
3.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Company (2018-2023)
3.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Company (2018-2023)
3.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Company (2018-2023)
3.2.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Company (2018-2023)
3.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company (2018-2023)
3.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Company
3.4 Key Manufacturers Hepatitis B Vaccine (Recombinant) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis B Vaccine (Recombinant) Product Location Distribution
3.4.2 Players Hepatitis B Vaccine (Recombinant) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HEPATITIS B VACCINE (RECOMBINANT) BY GEOGRAPHIC REGION
4.1 World Historic Hepatitis B Vaccine (Recombinant) Market Size by Geographic Region (2018-2023)
4.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hepatitis B Vaccine (Recombinant) Market Size by Country/Region (2018-2023)
4.2.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hepatitis B Vaccine (Recombinant) Sales Growth
4.4 APAC Hepatitis B Vaccine (Recombinant) Sales Growth
4.5 Europe Hepatitis B Vaccine (Recombinant) Sales Growth
4.6 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Growth
5 AMERICAS
5.1 Americas Hepatitis B Vaccine (Recombinant) Sales by Country
5.1.1 Americas Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023)
5.1.2 Americas Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023)
5.2 Americas Hepatitis B Vaccine (Recombinant) Sales by Type
5.3 Americas Hepatitis B Vaccine (Recombinant) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis B Vaccine (Recombinant) Sales by Region
6.1.1 APAC Hepatitis B Vaccine (Recombinant) Sales by Region (2018-2023)
6.1.2 APAC Hepatitis B Vaccine (Recombinant) Revenue by Region (2018-2023)
6.2 APAC Hepatitis B Vaccine (Recombinant) Sales by Type
6.3 APAC Hepatitis B Vaccine (Recombinant) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hepatitis B Vaccine (Recombinant) by Country
7.1.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023)
7.1.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023)
7.2 Europe Hepatitis B Vaccine (Recombinant) Sales by Type
7.3 Europe Hepatitis B Vaccine (Recombinant) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hepatitis B Vaccine (Recombinant) by Country
8.1.1 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023)
8.2 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Type
8.3 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis B Vaccine (Recombinant)
10.3 Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)
10.4 Industry Chain Structure of Hepatitis B Vaccine (Recombinant)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis B Vaccine (Recombinant) Distributors
11.3 Hepatitis B Vaccine (Recombinant) Customer
12 WORLD FORECAST REVIEW FOR HEPATITIS B VACCINE (RECOMBINANT) BY GEOGRAPHIC REGION
12.1 Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region
12.1.1 Global Hepatitis B Vaccine (Recombinant) Forecast by Region (2024-2029)
12.1.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis B Vaccine (Recombinant) Forecast by Type
12.7 Global Hepatitis B Vaccine (Recombinant) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Dynavax Technologies
13.4.1 Dynavax Technologies Company Information
13.4.2 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Dynavax Technologies Main Business Overview
13.4.5 Dynavax Technologies Latest Developments
13.5 LG Life Sciences
13.5.1 LG Life Sciences Company Information
13.5.2 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 LG Life Sciences Main Business Overview
13.5.5 LG Life Sciences Latest Developments
13.6 KM Biologics
13.6.1 KM Biologics Company Information
13.6.2 KM Biologics Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 KM Biologics Main Business Overview
13.6.5 KM Biologics Latest Developments
13.7 Shenzhen Kangtai Biological Products
13.7.1 Shenzhen Kangtai Biological Products Company Information
13.7.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shenzhen Kangtai Biological Products Main Business Overview
13.7.5 Shenzhen Kangtai Biological Products Latest Developments
13.8 Serum Institute
13.8.1 Serum Institute Company Information
13.8.2 Serum Institute Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
13.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Serum Institute Main Business Overview
13.8.5 Serum Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hepatitis B Vaccine (Recombinant) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hepatitis B Vaccine (Recombinant) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 10mcg/0.5ml
Table 4. Major Players of 10mcg/ml
Table 5. Global Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 6. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Table 7. Global Hepatitis B Vaccine (Recombinant) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2018-2023)
Table 9. Global Hepatitis B Vaccine (Recombinant) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 11. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Table 12. Global Hepatitis B Vaccine (Recombinant) Revenue by Application (2018-2023)
Table 13. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2018-2023)
Table 14. Global Hepatitis B Vaccine (Recombinant) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Hepatitis B Vaccine (Recombinant) Sales by Company (2018-2023) & (K Units)
Table 16. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Company (2018-2023)
Table 17. Global Hepatitis B Vaccine (Recombinant) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company (2018-2023)
Table 19. Global Hepatitis B Vaccine (Recombinant) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Hepatitis B Vaccine (Recombinant) Producing Area Distribution and Sales Area
Table 21. Players Hepatitis B Vaccine (Recombinant) Products Offered
Table 22. Hepatitis B Vaccine (Recombinant) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatitis B Vaccine (Recombinant) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hepatitis B Vaccine (Recombinant) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hepatitis B Vaccine (Recombinant) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hepatitis B Vaccine (Recombinant) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2018-2023)
Table 35. Americas Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2018-2023)
Table 37. Americas Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Hepatitis B Vaccine (Recombinant) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2018-2023)
Table 41. APAC Hepatitis B Vaccine (Recombinant) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2018-2023)
Table 43. APAC Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2018-2023)
Table 47. Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2018-2023)
Table 49. Europe Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Hepatitis B Vaccine (Recombinant)
Table 58. Key Market Challenges & Risks of Hepatitis B Vaccine (Recombinant)
Table 59. Key Industry Trends of Hepatitis B Vaccine (Recombinant)
Table 60. Hepatitis B Vaccine (Recombinant) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hepatitis B Vaccine (Recombinant) Distributors List
Table 63. Hepatitis B Vaccine (Recombinant) Customer List
Table 64. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GSK Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 80. GSK Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Merck Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 85. Merck Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Sanofi Pasteur Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 90. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi Pasteur Main Business
Table 92. Sanofi Pasteur Latest Developments
Table 93. Dynavax Technologies Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 94. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 95. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Dynavax Technologies Main Business
Table 97. Dynavax Technologies Latest Developments
Table 98. LG Life Sciences Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 99. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 100. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. LG Life Sciences Main Business
Table 102. LG Life Sciences Latest Developments
Table 103. KM Biologics Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 104. KM Biologics Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 105. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. KM Biologics Main Business
Table 107. KM Biologics Latest Developments
Table 108. Shenzhen Kangtai Biological Products Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 109. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 110. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Shenzhen Kangtai Biological Products Main Business
Table 112. Shenzhen Kangtai Biological Products Latest Developments
Table 113. Serum Institute Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 115. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Serum Institute Main Business
Table 117. Serum Institute Latest Developments
Table 1. Hepatitis B Vaccine (Recombinant) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hepatitis B Vaccine (Recombinant) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 10mcg/0.5ml
Table 4. Major Players of 10mcg/ml
Table 5. Global Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 6. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Table 7. Global Hepatitis B Vaccine (Recombinant) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2018-2023)
Table 9. Global Hepatitis B Vaccine (Recombinant) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 11. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Table 12. Global Hepatitis B Vaccine (Recombinant) Revenue by Application (2018-2023)
Table 13. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2018-2023)
Table 14. Global Hepatitis B Vaccine (Recombinant) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Hepatitis B Vaccine (Recombinant) Sales by Company (2018-2023) & (K Units)
Table 16. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Company (2018-2023)
Table 17. Global Hepatitis B Vaccine (Recombinant) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company (2018-2023)
Table 19. Global Hepatitis B Vaccine (Recombinant) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Hepatitis B Vaccine (Recombinant) Producing Area Distribution and Sales Area
Table 21. Players Hepatitis B Vaccine (Recombinant) Products Offered
Table 22. Hepatitis B Vaccine (Recombinant) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatitis B Vaccine (Recombinant) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hepatitis B Vaccine (Recombinant) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hepatitis B Vaccine (Recombinant) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hepatitis B Vaccine (Recombinant) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2018-2023)
Table 35. Americas Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2018-2023)
Table 37. Americas Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Hepatitis B Vaccine (Recombinant) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2018-2023)
Table 41. APAC Hepatitis B Vaccine (Recombinant) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2018-2023)
Table 43. APAC Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2018-2023)
Table 47. Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2018-2023)
Table 49. Europe Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Hepatitis B Vaccine (Recombinant)
Table 58. Key Market Challenges & Risks of Hepatitis B Vaccine (Recombinant)
Table 59. Key Industry Trends of Hepatitis B Vaccine (Recombinant)
Table 60. Hepatitis B Vaccine (Recombinant) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hepatitis B Vaccine (Recombinant) Distributors List
Table 63. Hepatitis B Vaccine (Recombinant) Customer List
Table 64. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GSK Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 80. GSK Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Merck Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 85. Merck Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Sanofi Pasteur Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 90. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Sanofi Pasteur Main Business
Table 92. Sanofi Pasteur Latest Developments
Table 93. Dynavax Technologies Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 94. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 95. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Dynavax Technologies Main Business
Table 97. Dynavax Technologies Latest Developments
Table 98. LG Life Sciences Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 99. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 100. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. LG Life Sciences Main Business
Table 102. LG Life Sciences Latest Developments
Table 103. KM Biologics Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 104. KM Biologics Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 105. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. KM Biologics Main Business
Table 107. KM Biologics Latest Developments
Table 108. Shenzhen Kangtai Biological Products Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 109. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 110. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Shenzhen Kangtai Biological Products Main Business
Table 112. Shenzhen Kangtai Biological Products Latest Developments
Table 113. Serum Institute Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute Hepatitis B Vaccine (Recombinant) Product Portfolios and Specifications
Table 115. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Serum Institute Main Business
Table 117. Serum Institute Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hepatitis B Vaccine (Recombinant)
Figure 2. Hepatitis B Vaccine (Recombinant) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hepatitis B Vaccine (Recombinant) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 10mcg/0.5ml
Figure 10. Product Picture of 10mcg/ml
Figure 11. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type in 2022
Figure 12. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2018-2023)
Figure 13. Hepatitis B Vaccine (Recombinant) Consumed in Newborn
Figure 14. Global Hepatitis B Vaccine (Recombinant) Market: Newborn (2018-2023) & (K Units)
Figure 15. Hepatitis B Vaccine (Recombinant) Consumed in Adult
Figure 16. Global Hepatitis B Vaccine (Recombinant) Market: Adult (2018-2023) & (K Units)
Figure 17. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2022)
Figure 18. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application in 2022
Figure 19. Hepatitis B Vaccine (Recombinant) Sales Market by Company in 2022 (K Units)
Figure 20. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Company in 2022
Figure 21. Hepatitis B Vaccine (Recombinant) Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company in 2022
Figure 23. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Hepatitis B Vaccine (Recombinant) Sales 2018-2023 (K Units)
Figure 26. Americas Hepatitis B Vaccine (Recombinant) Revenue 2018-2023 ($ Millions)
Figure 27. APAC Hepatitis B Vaccine (Recombinant) Sales 2018-2023 (K Units)
Figure 28. APAC Hepatitis B Vaccine (Recombinant) Revenue 2018-2023 ($ Millions)
Figure 29. Europe Hepatitis B Vaccine (Recombinant) Sales 2018-2023 (K Units)
Figure 30. Europe Hepatitis B Vaccine (Recombinant) Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue 2018-2023 ($ Millions)
Figure 33. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2022
Figure 34. Americas Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2022
Figure 35. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Figure 36. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Figure 37. United States Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2022
Figure 42. APAC Hepatitis B Vaccine (Recombinant) Revenue Market Share by Regions in 2022
Figure 43. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Figure 44. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Figure 45. China Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2022
Figure 53. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2022
Figure 54. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Figure 55. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Figure 56. Germany Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Figure 65. Egypt Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Hepatitis B Vaccine (Recombinant) in 2022
Figure 71. Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)
Figure 72. Industry Chain Structure of Hepatitis B Vaccine (Recombinant)
Figure 73. Channels of Distribution
Figure 74. Global Hepatitis B Vaccine (Recombinant) Sales Market Forecast by Region (2024-2029)
Figure 75. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Hepatitis B Vaccine (Recombinant)
Figure 2. Hepatitis B Vaccine (Recombinant) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hepatitis B Vaccine (Recombinant) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 10mcg/0.5ml
Figure 10. Product Picture of 10mcg/ml
Figure 11. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type in 2022
Figure 12. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2018-2023)
Figure 13. Hepatitis B Vaccine (Recombinant) Consumed in Newborn
Figure 14. Global Hepatitis B Vaccine (Recombinant) Market: Newborn (2018-2023) & (K Units)
Figure 15. Hepatitis B Vaccine (Recombinant) Consumed in Adult
Figure 16. Global Hepatitis B Vaccine (Recombinant) Market: Adult (2018-2023) & (K Units)
Figure 17. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2022)
Figure 18. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application in 2022
Figure 19. Hepatitis B Vaccine (Recombinant) Sales Market by Company in 2022 (K Units)
Figure 20. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Company in 2022
Figure 21. Hepatitis B Vaccine (Recombinant) Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company in 2022
Figure 23. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Hepatitis B Vaccine (Recombinant) Sales 2018-2023 (K Units)
Figure 26. Americas Hepatitis B Vaccine (Recombinant) Revenue 2018-2023 ($ Millions)
Figure 27. APAC Hepatitis B Vaccine (Recombinant) Sales 2018-2023 (K Units)
Figure 28. APAC Hepatitis B Vaccine (Recombinant) Revenue 2018-2023 ($ Millions)
Figure 29. Europe Hepatitis B Vaccine (Recombinant) Sales 2018-2023 (K Units)
Figure 30. Europe Hepatitis B Vaccine (Recombinant) Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue 2018-2023 ($ Millions)
Figure 33. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2022
Figure 34. Americas Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2022
Figure 35. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Figure 36. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Figure 37. United States Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2022
Figure 42. APAC Hepatitis B Vaccine (Recombinant) Revenue Market Share by Regions in 2022
Figure 43. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Figure 44. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Figure 45. China Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2022
Figure 53. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2022
Figure 54. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Figure 55. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Figure 56. Germany Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2018-2023)
Figure 65. Egypt Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Hepatitis B Vaccine (Recombinant) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Hepatitis B Vaccine (Recombinant) in 2022
Figure 71. Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)
Figure 72. Industry Chain Structure of Hepatitis B Vaccine (Recombinant)
Figure 73. Channels of Distribution
Figure 74. Global Hepatitis B Vaccine (Recombinant) Sales Market Forecast by Region (2024-2029)
Figure 75. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Application (2024-2029)
